VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia.
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia. Cytotherapy. 2021 09; 23(9):793-798.
View in:
PubMed
subject areas
Animals
HLA-A2 Antigen
Humans
Leukemia, Myeloid, Acute
Leukocytes, Mononuclear
Mice
Mice, Inbred NOD
Mice, SCID
Peptides
Peroxidase
T-Lymphocytes, Cytotoxic
authors with profiles
JEFFREY J MOLLDREM
QING MA
SIJIE LU